Preview

Rational Pharmacotherapy in Cardiology

Advanced search

ARTERIAL HYPERTENSION IN THE PRESENCE OF OVERWEIGHT AND OBESITY. THE CAPABILITIES OF AMLODIPINE AND LISINOPRIL COMBINATION. PART 1. FEATURES OF THE DAILY PROFILE OF BLOOD PRESSURE AND HEART DAMAGE AS A TARGET ORGAN IN PATIENTS WITH ARTERIAL HYPERTENSION IN COMBINATION WITH OVERWEIGHT AND OBESITY

https://doi.org/10.20996/1819-6446-2017-13-5-693-698

Full Text:

Abstract

The main mechanisms by which obesity and overweight exacerbate heart  damage as a target-organ of arterial hypertension (HT), and also increase the risk of cardiovascular complications are discussed. Features  of the daily profile of blood pressure and features of the pathogenesis of HT in obesity are considered. The description of morphofunctional changes of the heart in patients with HT and obesity, in particular the development of left ventricular hypertrophy, is presented separately. Metabolic factors of cardiac remodeling in obesity (peculiarities of adipogenesis, correlation with the volume of epicardial adipose tissue, the role of adiponectin and leptin) are also described. In describing the disorders of elastic properties of the myocardium in obesity and HT, the authors focus on the changes in the global longitudinal systolic and circumferential strains in this category of patients.

About the Authors

O. D. Ostroumova
A.I. Evdokimov Moscow State University of Medicine and Dentistry; I.M. Sechenov First Moscow State Medical University
Russian Federation

Olga D. Ostroumova – MD, PhD, Professor, Chair of Faculty Therapy and Occupational Diseases, A.I. Evdokimov MSU MD; Chair of Clinical Pharmacology and Propaedeutics of Internal Diseases, I.M. Sechenov FMSMU.

Delegatskaya ul. 20-1, Moscow, 127473; Trubetskaya ul. 8, Moscow, 119991



A. I. Kochetkov
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation

Alexey I. Kochetkov – MD, Assistant, Chair of Faculty Therapy and Occupational Diseases.

Delegatskaya ul. 20-1, Moscow, 127473



I. I. Kopchjonov
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation

Ivan I. Kopchjonov – MD, PhD, Associate Professor, Chair of Faculty Therapy and Occupational Diseases.

Delegatskaya ul. 20-1, Moscow, 127473



V. M. Fomina
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation

Vera M. Fomina – MD, PhD, Associate Professor, Chair of Faculty Therapy and Occupational Diseases.

Delegatskaya ul. 20-1, Moscow, 127473



References

1. Boytsov S.A., Deev A.D., Shalnova S.A. Mortality and risk factors for non-communicable diseases in Russia: Specific features, trends, and prognosis. Terapevticheskiy Arkhiv. 2017;89(1):5-13. (In Russ.) [Бойцов С.А., Деев А.Д., Шальнова С.А. Смертность и факторы риска неинфекционных заболеваний в России: особенности, динамика, прогноз. Терапевтический Архив. 2017;89(1):5-13]. doi: 10.17116/terarkh20178915-13.

2. Samorodskaja I.V., Bolotova E.Y., Boytsov S.A. Paradox of obesity and cardiovascular mortality. Kardiologiia. 2015;55(9):31-6. (In Russ.) [Самородская И.В., Болотова Е.В., Бойцов С.А. Парадокс ожирения и сердечно-сосудистая смертность. Кардиология. 2015;55(9):31-6]. doi: 10.18565/cardio.2015.9.31-36.

3. Zhang K., Huang F., Chen J., et al. Independent influence of overweight and obesity on the regression of left ventricular hypertrophy in hypertensive patients: a meta-analysis. Medicine. 2014;93(25):e130. doi: 10.1097/MD.0000000000000130.

4. An H.J., Kim W., Kang C., et al. Other Korean Ambulatory Blood Pressure Registry Investigators. Obesity increases blood pressure variability during the night. J Korean Soc Hypertens. 2014;20(1):1-7.

5. Tadic M., Cuspidi C., Ilic I., et al. The relationship between blood pressure variability, obesity and left atrial phasic function in hypertensive population. The International Journal of Cardiovascular Imaging 2016;32(4):603-12. doi: 10.1007/s10554-015-0822-8.

6. Ostroumova O.D., Kochetkov A.I., Lopukhina M.V. Comparative analysis of the efficacy of fixed-dose combinations of amlodipine/Lisinopril and bisoprolol/hydrochlorthiazide in patients with essential arterial hypertension combined with obesity and overweight. Rational Pharmacotherapy in Cardiology. 2017;13(4):457-67. (In Russ.) [Остроумова О.Д., Кочетков А.И., Лопухина М.В. Сравнительный анализ эффективности фиксированных комбинаций амлодипин/лизиноприл и бисопролол/гидрохлоротиазид у пациентов с гипертонической болезнью в сочетании с ожирением и избыточной массой тела. Рациональная Фармакотерапия в Кардиологии. 2017;13(4):443-53. doi:10.20996/1819-6446-2017-13-4-443-453].

7. Tutal E., Sayın B., Ertugrul D.T., et al. Is there a link between hyperuricemia, morning blood pressure surge, and non-dipping blood pressure pattern in metabolic syndrome patients? International Journal of Nephrology and Renovascular Disease. 2013;6(1):71-7. doi: 10.2147/IJNRD.S41384.

8. Lyzohub V.H., Dolynna O.V., Arutiunova K.Sh. Twenty four hour profile of arterial pressure in patients with hypertensive disease and concurrent obesity. Lik Sprava. 2002;(8):39-42.

9. Hassan M.O., Jaju D., Albarwani S., et al. Non-dipping blood pressure in the metabolic syndrome among Arabs of the Oman family study. Obesity (Silver Spring). 2007;15(10):2445-53. doi:10.1038/oby.2007.290.

10. Verdecchia P., Angeli F., Gattobigio R., et al. Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension. American Journal of Hypertension. 2007;20(2):154-61. doi:10.1016/j.amjhyper.2006.07.017.

11. Willich S.N. Circadian variation and triggering of cardiovascular events. Vascular Medicine. 1999;4(1):41-49. doi:10.1177/1358836X9900400108.

12. Fagard R.H., Thijs L., Staessen J. A., et al. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension. Journal of Human Hypertension. 2009;23(10):645-53. doi: 10.1038/jhh.2009.9.

13. Ohkubo T., Hozawa A., Yamaguchi J., et al. Prognostic significance of the nocturnal decline in blood pressure: the Ohasama study. Journal of Hypertension. 2002;20:2183-9. doi: 10.1097/00004872-200211000-00017.

14. Kario K., Pickering T.G., Matsuo T., et al. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001;38(4):852-7. doi: 10.1161/hy1001.092640.

15. Guo H., Tabara Y., Igase M., et al. Abnormal nocturnal blood pressure profile is associated with mild cognitive impairment in the elderly: the J-SHIPP study. Hypertens Res. 2010;33(1):32-6. doi: 10.1038/hr.2009.

16. Cuspidi C., Macca G., Sampieri L., et al. Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients. J Hypertens. 2001;19:1539-45.

17. Cuspidi C., Michev I., Meani S., et al. Reduced nocturnal fall in blood pressure, assessed by two ambulatory blood pressure monitorings and cardiac alterations in early phases of untreated essential hypertension. Journal of Human Hypertension. 2003;17:245-51. doi:10.1038/sj.jhh.1001546.

18. Pierdomenico S., Bucci A., Costantini F., et al. Circadian blood pressure changes and myocardial ischemia in hypertensive patients with coronary artery disease. J Am Coll Cardiol. 1998;31(7):1627-34. doi:10.1016/S0735-1097(98)00163-6.

19. Timio M., Venanzi S., Lolli S., et al. "Non-dipper" hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clinical Nephrology. 1995;43(6):382-7.

20. Cheng S., Xanthakis V., Sullivan L.M., et al. Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study. Circulation. 2010;122(6):570-8. doi: 10.1161/CIRCULATIONAHA.110.937821.

21. Marwick T.H., Gillebert T.C., Aurigemma G., et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). Eur Heart J Cardiovasc Imaging. 2015;16(6):577-605. doi: 10.1093/ehjci/jev076.

22. Sun T., Xie J., Zhu L., et al. Left ventricular hypertrophy and asymptomatic cardiac function impairment in chinese patients with simple obesity using echocardiography. Obesity Facts. 2015;8(3):210-9. doi: 10.1159/000435795.

23. Unsöld B., Bremen E., Didié M., et al. Differential PI3K signal transduction in obesity‑associated cardiac hypertrophy and response to ischemia. Obesity. 2015;23(1):90-9. doi: 10.1002/oby.20888.

24. Kannel W.B. Left ventricular hypertrophy as a risk factor in arterial hypertension. Eur Heart J. 1992;13(Suppl D):82-8. doi:10.1093/eurheartj/13.suppl_D.82.

25. Zhou Y.T., Grayburn P., Karim A., et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proceedings of the National Academy of Sciences. 2000;97(4):1784-9.

26. Brady T.M. The Role of Obesity in the Development of Left Ventricular Hypertrophy Among Children and Adolescents. Curr Hypertens Rep. 2016;18(1):3. doi: 10.1007/s11906-015-0608-3.

27. Mangner N., Scheuermann K., Winzer E., et al. Childhood obesity: impact on cardiac geometry and function. JACC: Cardiovascular Imaging. 2014;7(12):1198-205. doi: 10.1016/j.jcmg.2014.08.006.

28. Kang S.J., Lim H.S., Choi B.J., et al. Longitudinal strain and torsion assessed by two-dimensional speckle tracking correlate with the serum level of tissue inhibitor of matrix metalloproteinase-1, a marker of myocardial fibrosis, in patients with hypertension. J Am Soc Echocardiogr. 2008;21:907-11. doi: 10.1016/j.echo.2008.01.015.

29. Biering-Sørensen T., Biering-Sørensen S. R., Olsen F. J., et al. Global Longitudinal Strain by Echocardiography Predicts Long-Term Risk of Cardiovascular Morbidity and Mortality in a Low-Risk General Population. Circulation: Cardiovascular Imaging. 2017;10(3):e005521. doi: 10.1161/CIRCIMAGING.116.005521.

30. Ishizu T., Seo Y., Kameda Y., et al. Left ventricular strain and transmural distribution of structural remodeling in hypertensive heart disease. Hypertension. 2014; 63(3):500-6. doi: 10.1161/HYPERTENSIONAHA.113.02149.

31. Crendal E., Walther G., Vinet A., et al. Myocardial deformation and twist mechanics in adults with metabolic syndrome: impact of cumulative metabolic burden. Obesity. 2013;21(12):E679-E686. doi: 10.1002/oby.20537.

32. Krishnasamy R., Hawley C. M., Stanton T., et al. Left ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney disease. BMC Nephrology. 2015;16(1):106. doi: 10.1186/s12882-015-0098-1.

33. Вetin M., Kocaman S.A., Durakoğlugil M.E., et al. Effect of epicardial adipose tissue on diastolic functions and left atrial dimension in untreated hypertensive patients with normal systolic function. J Cardiol. 2013;61:359-64. doi: 10.1016/j.jjcc.2012.12.015.

34. Gonçalves N., Silva A.F., Rodrigues P.G., et al. Early cardiac changes induced by a hypercaloric Western-type diet in “subclinical” obesity. American Journal of Physiology-Heart and Circulatory Physiology. 2016;310(6):H655-H666. doi: 10.1152/ajpheart.00684.2015.

35. Mahfouz R. A., Gomma A., Goda M., Safwat M. Relation of left atrial stiffness to insulin resistance in obese children: Doppler strain imaging study. Echocardiography. 2015;32(7):1157-63. doi: 10.1111/echo.12824.


For citation:


Ostroumova O.D., Kochetkov A.I., Kopchjonov I.I., Fomina V.M. ARTERIAL HYPERTENSION IN THE PRESENCE OF OVERWEIGHT AND OBESITY. THE CAPABILITIES OF AMLODIPINE AND LISINOPRIL COMBINATION. PART 1. FEATURES OF THE DAILY PROFILE OF BLOOD PRESSURE AND HEART DAMAGE AS A TARGET ORGAN IN PATIENTS WITH ARTERIAL HYPERTENSION IN COMBINATION WITH OVERWEIGHT AND OBESITY. Rational Pharmacotherapy in Cardiology. 2017;13(5):693-698. (In Russ.) https://doi.org/10.20996/1819-6446-2017-13-5-693-698

Views: 195


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)